Package 0480-3297-56

{"route": ["ORAL"], "spl_id": "658f69a4-7121-43a9-8933-22a082740593", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0K2I505OTV", "0H73WJJ391"], "rxcui": ["1302827", "1302839", "1302850", "1313059"], "spl_set_id": ["918df93d-e033-4419-adcc-e21655ef8158"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-3297-56)", "package_ndc": "0480-3297-56", "marketing_start_date": "20250507"}], "brand_name": "Phentermine and topiramate", "product_id": "0480-3297_658f69a4-7121-43a9-8933-22a082740593", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Appetite Suppression [PE]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "0480-3297", "dea_schedule": "CIV", "generic_name": "Phentermine and topiramate", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phentermine and topiramate", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "3.75 mg/1"}, {"name": "TOPIRAMATE", "strength": "23 mg/1"}], "application_number": "ANDA204982", "marketing_category": "ANDA", "marketing_start_date": "20250507", "listing_expiration_date": "20271231"}